CD274 and cervical cancer: The variables included TGF-β score, CD47, other immune markers known to have an immunosuppressive role in the stroma: CXCL12, BAG2, CXCR4, BRD4, HMGA2, CSF1R, CD276, VTCN1, some previously reported to be associated with ICB response CD274, CTLA4, VTCN1, estimated immune cell abundance from RNAseq analysis (N = 9), and clinical-pathological features: age, gender, microsatellite instability (MSI) status, body mass index (BMI), disease type as endometrial, ovarian, or cervical cancer, histology type as endometrioid, serous, or squamous, and treatment cycle count (Fig. 1F).